ASAHI INTECC collects and analyzes all the latest information on medical technology in real time to identify the direction of next-generation medical technology and to develop medical devices to meet forthcoming needs. One field in particular that is expected to have a promising future is regenerative medicine. ASAHI INTECC is making full use of percutaneous transluminal coronary angioplasty (PTCA) device development technology to develop revolutionary regenerative medical treatment systems using cultured cells and genes. In order to strengthen its development structure in this field, ASAHI INTECC established the Kobe Research Center on Kobe Port Island in November of 2002. A variety of research institutions and universities are exist in this Kansai area, providing a rich and stimulating R&D environment. Making use of integrated development system that covers from raw materials to final products, ASAHI INTECC also strives to develop composite technology such as new processing technology as well as developing new materials for use in the medical field. An R&D center for high-performance wire rope and materials such as stainless steel and resin, as well as advanced delivery devices for use in the field of regenerative medicine.